• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西弗吉尼亚州新冠肺炎的临床特征与转归

Clinical Characteristics and Outcomes of COVID-19 in West Virginia.

作者信息

Wen Sijin, Prasad Apoorv, Freeland Kerri, Podury Sanjiti, Patel Jenil, Subedi Roshan, Khan Erum, Tandon Medha, Kataria Saurabh, Kimble Wesley, Sriwastava Shitiz

机构信息

Department of Biostatistics, West Virginia University, Morgantown, WV 26505, USA.

Berkeley Medical Center, Department of Neurology, West Virginia University, Morgantown, WV 25401, USA.

出版信息

Viruses. 2021 May 5;13(5):835. doi: 10.3390/v13050835.

DOI:10.3390/v13050835
PMID:34063160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8148202/
Abstract

This study examines the clinical characteristics, outcomes and types of management in SARS-CoV-2 infected patients, in the hospitals affiliated with West Virginia University. We included patients from West Virginia with SARS-CoV-2 infection between 15 April to 30 December 2020. Descriptive analysis was performed to summarize the characteristics of patients. Regression analyses were performed to assess the association between baseline characteristics and outcomes. Of 1742 patients, the mean age was 47.5 years (±22.7) and 54% of patients were female. Only 459 patients (26.3%) reported at least one baseline symptom, of which shortness of breath was most common. More than half had at least one comorbidity, with hypertension being the most common. There were 131 severe cases (7.5%), and 84 patients (4.8%) died despite treatment. The mean overall length of hospital stay was 2.6 days (±6.9). Age, male sex, and comorbidities were independent predictors of outcomes. In this study of patients with SARS-CoV-2 infection from West Virginia, older patients with underlying co-morbidities had poor outcomes, and the in-hospital mortality was similar to the national average.

摘要

本研究调查了西弗吉尼亚大学附属医院中感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)患者的临床特征、治疗结果及管理类型。我们纳入了2020年4月15日至12月30日期间来自西弗吉尼亚州的SARS-CoV-2感染患者。进行描述性分析以总结患者特征。进行回归分析以评估基线特征与治疗结果之间的关联。在1742名患者中,平均年龄为47.5岁(±22.7),54%的患者为女性。只有459名患者(26.3%)报告至少有一种基线症状,其中呼吸急促最为常见。超过一半的患者至少有一种合并症,高血压最为常见。有131例重症病例(7.5%),84名患者(4.8%)尽管接受了治疗仍死亡。平均住院总时长为2.6天(±6.9)。年龄、男性性别和合并症是治疗结果的独立预测因素。在这项对来自西弗吉尼亚州的SARS-CoV-2感染患者的研究中,有基础合并症的老年患者治疗结果较差,住院死亡率与全国平均水平相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1770/8148202/b5162b69e82a/viruses-13-00835-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1770/8148202/76abda90dd00/viruses-13-00835-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1770/8148202/b5162b69e82a/viruses-13-00835-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1770/8148202/76abda90dd00/viruses-13-00835-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1770/8148202/b5162b69e82a/viruses-13-00835-g002.jpg

相似文献

1
Clinical Characteristics and Outcomes of COVID-19 in West Virginia.西弗吉尼亚州新冠肺炎的临床特征与转归
Viruses. 2021 May 5;13(5):835. doi: 10.3390/v13050835.
2
Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.加拿大疫情第一阶段住院和重症监护的 COVID-19 患者的特征和结局:一项全国性队列研究。
CMAJ Open. 2021 Mar 8;9(1):E181-E188. doi: 10.9778/cmajo.20200250. Print 2021 Jan-Mar.
3
Persistence and Protective Potential of SARS-CoV-2 Antibody Levels After COVID-19 Vaccination in a West Virginia Nursing Home Cohort.西弗吉尼亚州养老院队列中 COVID-19 疫苗接种后 SARS-CoV-2 抗体水平的持久性和保护潜力。
JAMA Netw Open. 2022 Sep 1;5(9):e2231334. doi: 10.1001/jamanetworkopen.2022.31334.
4
Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.在新冠疫情早期,一家筛查诊所的冠状病毒病(COVID-19)病例的流行病学和临床特征:一项单中心研究。
J Med Microbiol. 2020 Aug;69(8):1114-1123. doi: 10.1099/jmm.0.001231.
5
Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.利用美国国家 COVID 队列协作的数据,对美国成年人中 SARS-CoV-2 感染的临床特征和临床严重程度进行临床描述和预测。
JAMA Netw Open. 2021 Jul 1;4(7):e2116901. doi: 10.1001/jamanetworkopen.2021.16901.
6
Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.丹麦与感染 SARS-CoV-2 谱系 B.1.1.7 相关的住院风险:一项观察性队列研究。
Lancet Infect Dis. 2021 Nov;21(11):1507-1517. doi: 10.1016/S1473-3099(21)00290-5. Epub 2021 Jun 23.
7
Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study.伊朗克尔曼沙阿省 27256 例住院 COVID-19 患者的人口统计学、临床特征和结局:一项回顾性一年队列研究。
BMC Infect Dis. 2022 Mar 31;22(1):319. doi: 10.1186/s12879-022-07312-7.
8
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis.北美多发性硬化症患者SARS-CoV-2感染的相关结局和风险因素
JAMA Neurol. 2021 Jun 1;78(6):699-708. doi: 10.1001/jamaneurol.2021.0688.
9
Prevalence, management, and outcomes of SARS-CoV-2 infections in older people and those with dementia in mental health wards in London, UK: a retrospective observational study.英国伦敦心理健康病房中老年人及痴呆症患者的新型冠状病毒2感染的患病率、管理及结局:一项回顾性观察研究
Lancet Psychiatry. 2020 Dec;7(12):1054-1063. doi: 10.1016/S2215-0366(20)30434-X. Epub 2020 Oct 5.
10
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.与美国 COVID-19 患者住院死亡率相关的风险因素。
JAMA Netw Open. 2020 Dec 1;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058.

引用本文的文献

1
Prevalence of comorbidities and their association with disease severity and mortality in COVID-19 patients: A systematic review and meta-analysis.COVID-19患者合并症的患病率及其与疾病严重程度和死亡率的关联:一项系统综述和荟萃分析。
J Multimorb Comorb. 2025 Aug 28;15:26335565251371256. doi: 10.1177/26335565251371256. eCollection 2025 Jan-Dec.
2
Clinical characteristics and outcomes of hospitalized patients with COVID-19 in a Brazilian hospital: a retrospective study of the first and second waves.巴西一家医院新冠肺炎住院患者的临床特征及结局:对第一波和第二波疫情的回顾性研究
IJID Reg. 2022 Jun;3:189-195. doi: 10.1016/j.ijregi.2022.04.002. Epub 2022 Apr 14.
3

本文引用的文献

1
Outcomes and Mortality Among Adults Hospitalized With COVID-19 at US Medical Centers.美国医疗中心收治的 COVID-19 成年患者的结局和死亡率。
JAMA Netw Open. 2021 Mar 1;4(3):e210417. doi: 10.1001/jamanetworkopen.2021.0417.
2
Impacts of the COVID-19 pandemic on rural America.新冠疫情对美国农村的影响。
Proc Natl Acad Sci U S A. 2021 Jan 5;118(1). doi: 10.1073/pnas.2019378118.
3
A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19).
Clinical Characteristics, Risk Factors, and Outcomes Among a Large Midwestern U.S. Cohort of Patients Hospitalized With COVID-19 Prior to Vaccine Availability.
美国中西部一大群在疫苗可用之前因新冠肺炎住院的患者的临床特征、风险因素及预后
J Patient Cent Res Rev. 2022 Apr 18;9(2):132-141. doi: 10.17294/2330-0698.1889. eCollection 2022 Spring.
一项多中心、随机、开放标签、对照试验,旨在评估羟氯喹的疗效和耐受性,以及一项针对轻症至中度 2019 冠状病毒病(COVID-19)成年患者的回顾性研究。
PLoS One. 2020 Dec 2;15(12):e0242763. doi: 10.1371/journal.pone.0242763. eCollection 2020.
4
Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis.COVID-19中的种族与临床结局:一项系统评价与荟萃分析。
EClinicalMedicine. 2020 Dec;29:100630. doi: 10.1016/j.eclinm.2020.100630. Epub 2020 Nov 12.
5
Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.心血管合并症是 COVID-19 严重感染或死亡的预测因素。
Eur Heart J Qual Care Clin Outcomes. 2021 Mar 15;7(2):172-180. doi: 10.1093/ehjqcco/qcaa081.
6
Understanding factors influencing the length of hospital stay among non-severe COVID-19 patients: A retrospective cohort study in a Fangcang shelter hospital.了解非重症 COVID-19 患者住院时间长短的影响因素:方仓庇护医院的回顾性队列研究。
PLoS One. 2020 Oct 21;15(10):e0240959. doi: 10.1371/journal.pone.0240959. eCollection 2020.
7
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort).在一家三级医疗中心收治的患有严重新型冠状病毒肺炎(COVID-19)并接受抗病毒药物、抗疟药、糖皮质激素或使用托珠单抗或环孢素进行免疫调节的住院成人患者的临床特征及转归:一项回顾性观察性研究(COQUIMA队列研究)
EClinicalMedicine. 2020 Nov;28:100591. doi: 10.1016/j.eclinm.2020.100591. Epub 2020 Oct 15.
8
Factors significantly associated with COVID-19 severity in symptomatic patients: A retrospective single-center study.与有症状 COVID-19 患者严重程度显著相关的因素:一项回顾性单中心研究。
J Infect Chemother. 2021 Jan;27(1):76-82. doi: 10.1016/j.jiac.2020.09.022. Epub 2020 Oct 10.
9
Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics.基于胸部 CT 与临床特征的 COVID-19 肺炎患者疾病进展的早期预测。
Nat Commun. 2020 Oct 2;11(1):4968. doi: 10.1038/s41467-020-18786-x.
10
Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York.纽约市一家城市医疗中心的 COVID-19 患者种族与合并症及生存率的关系。
JAMA Netw Open. 2020 Sep 1;3(9):e2019795. doi: 10.1001/jamanetworkopen.2020.19795.